ABN AMRO Bank N.V. Sells 8,085 Shares of Ventas, Inc. $VTR

ABN AMRO Bank N.V. trimmed its position in shares of Ventas, Inc. (NYSE:VTR) by 7.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 93,730 shares of the real estate investment trust’s stock after selling 8,085 shares during the quarter. ABN AMRO Bank N.V.’s holdings in Ventas were worth $7,709,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of VTR. Bridgewater Advisors Inc. raised its holdings in Ventas by 2.0% in the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after buying an additional 133 shares during the last quarter. IHT Wealth Management LLC boosted its stake in Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after purchasing an additional 137 shares during the last quarter. True Wealth Design LLC increased its holdings in shares of Ventas by 32.0% in the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 138 shares in the last quarter. Cigna Investments Inc. New increased its holdings in shares of Ventas by 3.3% in the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after purchasing an additional 142 shares in the last quarter. Finally, Parallel Advisors LLC raised its stake in shares of Ventas by 4.6% in the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after purchasing an additional 175 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on VTR shares. UBS Group upped their price target on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 price objective on shares of Ventas in a report on Monday, May 4th. Citigroup upped their target price on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, May 1st. The Goldman Sachs Group restated a “buy” rating and set a $110.00 target price on shares of Ventas in a research note on Tuesday, May 19th. Finally, Mizuho set a $98.00 price target on shares of Ventas in a report on Friday, May 22nd. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

Ventas Stock Up 1.9%

VTR stock opened at $89.06 on Friday. The company has a market cap of $43.30 billion, a price-to-earnings ratio of 161.92, a P/E/G ratio of 1.91 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The business’s 50-day moving average is $85.21 and its two-hundred day moving average is $82.79. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $91.06.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the company earned $0.84 EPS. Ventas’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, June 30th. Ventas’s payout ratio is 378.18%.

Insider Buying and Selling

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at $2,557,079.80. This represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by corporate insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.